Rapport Shares Soar On Positive Anti-Seizure Treatment Results – MarketWatch

Written by

admin

in

  1. Rapport Shares Soar On Positive Anti-Seizure Treatment Results  MarketWatch
  2. Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025  Yahoo Finance
  3. Rapport Therapeutics stock soars after positive Phase 2a seizure drug results  Investing.com
  4. Rapport Therapeutics To Report Epilepsy Trial Results On Monday – Will The Stock Surge Or Tumble?  Nasdaq
  5. Rapport Therapeutics soars 23% on release of phase 2 data for seizure asset  MSN

Continue Reading

More posts